Spectrum and Classification of CFTR and ADGRG2 Variants in Chinese Patients With Isolated CAVD: A Large Cohort Study and Risk Assessment of CFTR Variant Carriage in Couples

Read full text
Authors: P B Yuan, 梁中锟, L Y Zhou, Xiaohui Ji, Shengran Wang, Jing Zhang, Jin Li, S M Xie, Y.Y. Li, Tuerxunayi Yalikun, Qipeng Sun, H T Chen
Cited by: 1
References: 25

Abstract

Congenital absence of the vas deferens (CAVD) is a major cause of obstructive azoospermia and male infertility, with its genetic etiology primarily associated with CFTR (autosomal recessive) and ADGRG2 (X-linked) mutations. However, the genetic spectrum and classification of variants in isolated congenital absence of the vas deferens (iCAVD), as well as the risk of CFTR variant carriage in affected couples, remain incompletely understood. In this cross-sectional study, we enrolled 199 Chinese iCAVD patients and 148 female partners between 2012 and 2024. CFTR and ADGRG2 variants were identified in 74.87% of iCAVD patients, with CFTR being the predominant pathogenic gene. Notably, 10.14% of couples carried shared pathogenic or likely pathogenic CFTR variants, highlighting the potential reproductive risks. The most common pathogenic variants were CFTR c.1210-12T (Yu et al., 2012) (5T) and c.4056G > C (p.Gln1352His), whereas c.1666A > G (p.Ile556Val) was classified as likely benign. The c.4056G > C variant exhibited significant regional ethnic characteristics. Furthermore, genotype-phenotype correlation analysis revealed significant differences in semen volume, pH, and fructose levels among different variant subgroups in CBAVD patients. Collectively, these findings provide a comprehensive overview of the genotype-phenotype landscape in a large iCAVD cohort, emphasizing variant classification and reproductive risks associated with CFTR and ADGRG2. This study offers valuable insights for genetic counseling and reproductive planning in affected couples.

Fields of Study & Subjects

Sperm and Testicular Function Ovarian function and disorders Blood Coagulation and Thrombosis Mechanisms

Publication details

Journal / source
Human Mutation
Publisher
Wiley
Volume
2026
Issue
1
Pages
5588277–5588277
Publication date
1 January 2026
Language
EN